VXRT VXRT

Vaxart Stock Price

1.20
-0.04 (-3.23%)
Upgrade to Real-Time
Regular Market
1.20
Volume 217,392
Bid Price 1.20
Ask Price 1.21
News -
Day High 1.25

Low
1.17

52 Week Range

High
8.13

Day Low 1.20
Company Name Stock Ticker Symbol Market Type
Vaxart Inc VXRT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -3.23% 1.20 09:54:18
Open Price Low Price High Price Close Price Prev Close
1.24 1.20 1.25 1.24
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
928 217,392 $ 1.23 $ 266,568 - 1.17 - 8.13
Last Trade Time Type Quantity Stock Price Currency
09:54:18 184 $ 1.20 USD

Period:

Draw Mode:

Vaxart Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 157.50M 131.25M 117.29M $ 892.00k $ - -0.58 -1.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 428.55k 2.50%

more financials information »

Vaxart News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VXRT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.341.381.171.261,922,033-0.14-10.45%
1 Month1.611.7251.171.453,110,742-0.41-25.47%
3 Months2.722.93591.171.873,028,895-1.52-55.88%
6 Months3.724.6151.172.762,810,540-2.52-67.74%
1 Year7.708.131.173.942,839,297-6.50-84.42%
3 Years0.354524.900.28057.429,999,9880.8455238.5%
5 Years7.46924.900.25437.316,247,278-6.27-83.93%

Vaxart Description

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.